

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.97075578 |
| 2 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.52575855 |
| 3 | DNA deamination (GO:0045006) | 4.28060550 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.03927245 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.03927245 |
| 6 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.02436810 |
| 7 | respiratory chain complex IV assembly (GO:0008535) | 3.89149042 |
| 8 | cytochrome complex assembly (GO:0017004) | 3.82486601 |
| 9 | rRNA modification (GO:0000154) | 3.81734167 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.78651956 |
| 11 | protein complex biogenesis (GO:0070271) | 3.75165150 |
| 12 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.61911372 |
| 13 | ATP synthesis coupled proton transport (GO:0015986) | 3.56378578 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.56378578 |
| 15 | rRNA methylation (GO:0031167) | 3.54048628 |
| 16 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.42421569 |
| 17 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.42421569 |
| 18 | NADH dehydrogenase complex assembly (GO:0010257) | 3.42421569 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34875091 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 3.34832031 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.34832031 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.34599360 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.34599360 |
| 24 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.30954838 |
| 25 | protein neddylation (GO:0045116) | 3.27174354 |
| 26 | respiratory electron transport chain (GO:0022904) | 3.24096082 |
| 27 | proteasome assembly (GO:0043248) | 3.23892457 |
| 28 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.22866028 |
| 29 | cytidine deamination (GO:0009972) | 3.22630432 |
| 30 | cytidine metabolic process (GO:0046087) | 3.22630432 |
| 31 | cytidine catabolic process (GO:0006216) | 3.22630432 |
| 32 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.21508336 |
| 33 | deoxyribonucleotide catabolic process (GO:0009264) | 3.21469474 |
| 34 | electron transport chain (GO:0022900) | 3.20981109 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19011855 |
| 36 | purine nucleotide salvage (GO:0032261) | 3.17297724 |
| 37 | deoxyribose phosphate catabolic process (GO:0046386) | 3.14939304 |
| 38 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10588784 |
| 39 | aromatic amino acid family catabolic process (GO:0009074) | 3.10480190 |
| 40 | cellular response to zinc ion (GO:0071294) | 3.07220871 |
| 41 | valine metabolic process (GO:0006573) | 3.07150323 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.06522151 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06244195 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.02496309 |
| 45 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.99433043 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 2.97124978 |
| 47 | chaperone-mediated protein transport (GO:0072321) | 2.94570719 |
| 48 | complement activation, classical pathway (GO:0006958) | 2.94427844 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 2.89706342 |
| 50 | purine-containing compound salvage (GO:0043101) | 2.89679314 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.89644825 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86255728 |
| 53 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.85844266 |
| 54 | indolalkylamine catabolic process (GO:0046218) | 2.85693108 |
| 55 | tryptophan catabolic process (GO:0006569) | 2.85693108 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 2.85693108 |
| 57 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.85428801 |
| 58 | alpha-linolenic acid metabolic process (GO:0036109) | 2.81929717 |
| 59 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.81747161 |
| 60 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.81747161 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.78098566 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77576325 |
| 63 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.77365299 |
| 64 | cysteine metabolic process (GO:0006534) | 2.73982505 |
| 65 | sulfur amino acid catabolic process (GO:0000098) | 2.73826953 |
| 66 | autophagic vacuole fusion (GO:0000046) | 2.73210867 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 2.73172798 |
| 68 | metallo-sulfur cluster assembly (GO:0031163) | 2.71155888 |
| 69 | iron-sulfur cluster assembly (GO:0016226) | 2.71155888 |
| 70 | negative regulation of ligase activity (GO:0051352) | 2.71143514 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71143514 |
| 72 | complement activation (GO:0006956) | 2.71143221 |
| 73 | GMP metabolic process (GO:0046037) | 2.70329359 |
| 74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67502898 |
| 75 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67502898 |
| 76 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67502898 |
| 77 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.67196294 |
| 78 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.67196294 |
| 79 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.64470844 |
| 80 | kynurenine metabolic process (GO:0070189) | 2.63878722 |
| 81 | deoxyribose phosphate metabolic process (GO:0019692) | 2.61536025 |
| 82 | platelet dense granule organization (GO:0060155) | 2.61265140 |
| 83 | glyoxylate metabolic process (GO:0046487) | 2.60588652 |
| 84 | regulation of B cell apoptotic process (GO:0002902) | 2.60203834 |
| 85 | piRNA metabolic process (GO:0034587) | 2.59963104 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.58506300 |
| 87 | regulation of B cell differentiation (GO:0045577) | 2.58136762 |
| 88 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.56283898 |
| 89 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.55909229 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.55882648 |
| 91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.55882648 |
| 92 | tryptophan metabolic process (GO:0006568) | 2.55625304 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55393151 |
| 94 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.54914830 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.54888727 |
| 96 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.54200045 |
| 97 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.54175435 |
| 98 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.54175435 |
| 99 | pseudouridine synthesis (GO:0001522) | 2.53274224 |
| 100 | ethanol oxidation (GO:0006069) | 2.53228989 |
| 101 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.52252406 |
| 102 | sperm-egg recognition (GO:0035036) | 2.51370130 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 2.51356148 |
| 104 | response to interferon-beta (GO:0035456) | 2.50645770 |
| 105 | bile acid biosynthetic process (GO:0006699) | 2.49572401 |
| 106 | B cell mediated immunity (GO:0019724) | 2.49569846 |
| 107 | organelle membrane fusion (GO:0090174) | 2.49542362 |
| 108 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.49302958 |
| 109 | positive thymic T cell selection (GO:0045059) | 2.48801434 |
| 110 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48568423 |
| 111 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.48528238 |
| 112 | mast cell activation (GO:0045576) | 2.48514242 |
| 113 | complement activation, alternative pathway (GO:0006957) | 2.48125075 |
| 114 | negative T cell selection (GO:0043383) | 2.47704842 |
| 115 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.46923912 |
| 116 | mitochondrial calcium ion transport (GO:0006851) | 2.45149076 |
| 117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44916957 |
| 118 | plasma lipoprotein particle clearance (GO:0034381) | 2.44745144 |
| 119 | cell-cell recognition (GO:0009988) | 2.43732015 |
| 120 | regulation of triglyceride catabolic process (GO:0010896) | 2.43551354 |
| 121 | glycine metabolic process (GO:0006544) | 2.43204974 |
| 122 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.42924640 |
| 123 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.42924640 |
| 124 | oxidative phosphorylation (GO:0006119) | 2.42507590 |
| 125 | GDP-mannose metabolic process (GO:0019673) | 2.42458981 |
| 126 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.41951493 |
| 127 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.40324331 |
| 128 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.40022984 |
| 129 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.38984957 |
| 130 | nucleotide salvage (GO:0043173) | 2.38915005 |
| 131 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.38470863 |
| 132 | protein targeting to mitochondrion (GO:0006626) | 2.37949605 |
| 133 | multicellular organism reproduction (GO:0032504) | 2.37411781 |
| 134 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.37350264 |
| 135 | amino-acid betaine metabolic process (GO:0006577) | 2.36660533 |
| 136 | urea metabolic process (GO:0019627) | 2.35888518 |
| 137 | urea cycle (GO:0000050) | 2.35888518 |
| 138 | base-excision repair, AP site formation (GO:0006285) | 2.35148443 |
| 139 | fatty acid beta-oxidation (GO:0006635) | 2.34992272 |
| 140 | positive regulation of ligase activity (GO:0051351) | 2.34929050 |
| 141 | nucleoside salvage (GO:0043174) | 2.34581674 |
| 142 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.34341397 |
| 143 | sperm motility (GO:0030317) | 2.34040781 |
| 144 | regulation of humoral immune response (GO:0002920) | 2.33220395 |
| 145 | L-serine metabolic process (GO:0006563) | 2.33072061 |
| 146 | serine family amino acid metabolic process (GO:0009069) | 2.32709334 |
| 147 | positive regulation of granulocyte differentiation (GO:0030854) | 2.32548449 |
| 148 | hydrogen ion transmembrane transport (GO:1902600) | 2.32010727 |
| 149 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31799094 |
| 150 | high-density lipoprotein particle remodeling (GO:0034375) | 2.30350810 |
| 151 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.28647731 |
| 152 | regulation of protein activation cascade (GO:2000257) | 2.28394750 |
| 153 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.28122415 |
| 154 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.28122415 |
| 155 | binding of sperm to zona pellucida (GO:0007339) | 2.27493863 |
| 156 | amyloid precursor protein catabolic process (GO:0042987) | 2.27220603 |
| 157 | regulation of cholesterol esterification (GO:0010872) | 2.27062047 |
| 158 | acetyl-CoA metabolic process (GO:0006084) | 2.26446865 |
| 159 | regulation of superoxide anion generation (GO:0032928) | 2.26323437 |
| 160 | positive regulation of antigen processing and presentation (GO:0002579) | 2.25174527 |
| 161 | nitrogen cycle metabolic process (GO:0071941) | 2.24707820 |
| 162 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.24000790 |
| 163 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.23787134 |
| 164 | protein activation cascade (GO:0072376) | 2.23642074 |
| 165 | proline biosynthetic process (GO:0006561) | 2.23031514 |
| 166 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.21137184 |
| 167 | natural killer cell mediated immunity (GO:0002228) | 2.21137184 |
| 168 | positive regulation of humoral immune response (GO:0002922) | 2.18533306 |
| 169 | serine family amino acid catabolic process (GO:0009071) | 2.17136268 |
| 170 | ethanol metabolic process (GO:0006067) | 2.17009524 |
| 171 | ribosomal small subunit assembly (GO:0000028) | 2.16836087 |
| 172 | regulation of complement activation (GO:0030449) | 2.16691125 |
| 173 | thymic T cell selection (GO:0045061) | 2.16351888 |
| 174 | T cell migration (GO:0072678) | 2.14634382 |
| 175 | primary alcohol catabolic process (GO:0034310) | 2.14455739 |
| 176 | negative regulation of sterol transport (GO:0032372) | 2.13602242 |
| 177 | negative regulation of cholesterol transport (GO:0032375) | 2.13602242 |
| 178 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.13516772 |
| 179 | negative regulation of B cell apoptotic process (GO:0002903) | 2.12785844 |
| 180 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.12301431 |
| 181 | fatty acid catabolic process (GO:0009062) | 2.10160518 |
| 182 | bile acid metabolic process (GO:0008206) | 2.09878415 |
| 183 | proline metabolic process (GO:0006560) | 2.09622250 |
| 184 | aromatic amino acid family metabolic process (GO:0009072) | 2.09435839 |
| 185 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.09333745 |
| 186 | tolerance induction (GO:0002507) | 2.08960712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.04993754 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.95475790 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.86889370 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76911384 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.73015738 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.69965571 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59546651 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59098283 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.53068621 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49080816 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.33587235 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33359249 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.30878623 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27236872 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23250970 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.09543848 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.07469288 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.05799852 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.04087154 |
| 20 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.03551909 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 1.88382828 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.85083225 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80966779 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75713520 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.75296656 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72128156 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70358286 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66769179 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66766959 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65814830 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65363101 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.62503440 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.58056623 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55959314 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.55653483 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55406930 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55039248 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.54419842 |
| 39 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52562837 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52478452 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52172152 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51836692 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48749637 |
| 44 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.48602966 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47057045 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46658912 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44564801 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44212305 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43006721 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.41983478 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39396087 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.37845872 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37775982 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37214081 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35973832 |
| 56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35835841 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35695391 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33431426 |
| 59 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.33394573 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32035654 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.31173341 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30403255 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.28772585 |
| 64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27102256 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26733172 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25023422 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23922473 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23393108 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23053164 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21472317 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20878194 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.20768251 |
| 73 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20454661 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20332071 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19351530 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.19277855 |
| 77 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18809317 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16579398 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16373449 |
| 80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16345521 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16031101 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15837648 |
| 83 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.13190378 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12685955 |
| 85 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.12311264 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12185801 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10590325 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10561632 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10546510 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09891303 |
| 91 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09640679 |
| 92 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09500529 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09469991 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08567774 |
| 95 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08442339 |
| 96 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08380060 |
| 97 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07640528 |
| 98 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07057446 |
| 99 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06510107 |
| 100 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05539662 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05141550 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04319787 |
| 103 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03907561 |
| 104 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03635187 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03355067 |
| 106 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.03209526 |
| 107 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.02538115 |
| 108 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02457931 |
| 109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01995221 |
| 110 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01948155 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00983826 |
| 112 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00714094 |
| 113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00172870 |
| 114 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99648561 |
| 115 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99542467 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99169463 |
| 117 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99149399 |
| 118 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98675024 |
| 119 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98617126 |
| 120 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98400889 |
| 121 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96673028 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96306622 |
| 123 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96262985 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95384852 |
| 125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94489454 |
| 126 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93214526 |
| 127 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93213139 |
| 128 | P300_27268052_Chip-Seq_Bcells_Human | 0.90936104 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90681140 |
| 130 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88835525 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88712441 |
| 132 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.88224886 |
| 133 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87144807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.62879795 |
| 2 | MP0000685_abnormal_immune_system | 3.16779031 |
| 3 | MP0005360_urolithiasis | 3.15938724 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.03981082 |
| 5 | MP0001790_abnormal_immune_system | 2.78652388 |
| 6 | MP0005387_immune_system_phenotype | 2.78652388 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.75535968 |
| 8 | MP0001800_abnormal_humoral_immune | 2.70527095 |
| 9 | MP0005410_abnormal_fertilization | 2.45657090 |
| 10 | MP0005365_abnormal_bile_salt | 2.39767161 |
| 11 | MP0005671_abnormal_response_to | 2.24512992 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.23204670 |
| 13 | MP0009840_abnormal_foam_cell | 2.17316085 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.16448446 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.09547205 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.08503532 |
| 17 | MP0002723_abnormal_immune_serum | 2.01868849 |
| 18 | MP0000372_irregular_coat_pigmentation | 1.95856216 |
| 19 | MP0009785_altered_susceptibility_to | 1.93863408 |
| 20 | MP0001853_heart_inflammation | 1.93377157 |
| 21 | MP0005025_abnormal_response_to | 1.86689715 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.83802396 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.83210462 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82985377 |
| 25 | MP0001819_abnormal_immune_cell | 1.80060045 |
| 26 | MP0003436_decreased_susceptibility_to | 1.71562673 |
| 27 | MP0008057_abnormal_DNA_replication | 1.67655221 |
| 28 | MP0002398_abnormal_bone_marrow | 1.64985239 |
| 29 | MP0001873_stomach_inflammation | 1.63267336 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.62475082 |
| 31 | MP0002163_abnormal_gland_morphology | 1.61486213 |
| 32 | MP0003786_premature_aging | 1.61168334 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.61032920 |
| 34 | MP0000716_abnormal_immune_system | 1.60450352 |
| 35 | MP0005670_abnormal_white_adipose | 1.57855671 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.57134226 |
| 37 | MP0006082_CNS_inflammation | 1.56689376 |
| 38 | MP0002405_respiratory_system_inflammati | 1.56378739 |
| 39 | MP0003186_abnormal_redox_activity | 1.55456586 |
| 40 | MP0005451_abnormal_body_composition | 1.54955096 |
| 41 | MP0002419_abnormal_innate_immunity | 1.53811436 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.53566279 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.51602688 |
| 44 | MP0000609_abnormal_liver_physiology | 1.49930874 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.47069369 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.45806685 |
| 47 | MP0005332_abnormal_amino_acid | 1.43775236 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.43753085 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.42473741 |
| 50 | MP0002722_abnormal_immune_system | 1.39504110 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.38269243 |
| 52 | MP0002429_abnormal_blood_cell | 1.38264053 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.37512270 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.36815146 |
| 55 | MP0003252_abnormal_bile_duct | 1.36554899 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.36100820 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.35114313 |
| 58 | MP0004947_skin_inflammation | 1.35020330 |
| 59 | MP0003724_increased_susceptibility_to | 1.34800082 |
| 60 | MP0008469_abnormal_protein_level | 1.30793969 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.29978088 |
| 62 | MP0003718_maternal_effect | 1.24064157 |
| 63 | MP0004147_increased_porphyrin_level | 1.22425973 |
| 64 | MP0004381_abnormal_hair_follicle | 1.21914024 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.21145626 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.20983311 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.20226054 |
| 68 | MP0002254_reproductive_system_inflammat | 1.19679919 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.16898838 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14495348 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.14299082 |
| 72 | MP0003195_calcinosis | 1.12876256 |
| 73 | MP0001764_abnormal_homeostasis | 1.12207255 |
| 74 | MP0002006_tumorigenesis | 1.09653774 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.08700531 |
| 76 | MP0005083_abnormal_biliary_tract | 1.08309872 |
| 77 | MP0002693_abnormal_pancreas_physiology | 1.08283730 |
| 78 | MP0005310_abnormal_salivary_gland | 1.06876325 |
| 79 | MP0003011_delayed_dark_adaptation | 1.03809519 |
| 80 | MP0008872_abnormal_physiological_respon | 1.03309725 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.03247666 |
| 82 | MP0009763_increased_sensitivity_to | 1.01937816 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 1.01304876 |
| 84 | MP0010094_abnormal_chromosome_stability | 1.01189608 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.99745772 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 0.99123307 |
| 87 | MP0003075_altered_response_to | 0.98993521 |
| 88 | MP0001929_abnormal_gametogenesis | 0.98725214 |
| 89 | MP0003693_abnormal_embryo_hatching | 0.98466834 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.97170778 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.97006994 |
| 92 | MP0002132_abnormal_respiratory_system | 0.95398961 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.94010430 |
| 94 | MP0002933_joint_inflammation | 0.93873035 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.93645963 |
| 96 | MP0003077_abnormal_cell_cycle | 0.93232220 |
| 97 | MP0009764_decreased_sensitivity_to | 0.92474786 |
| 98 | MP0000598_abnormal_liver_morphology | 0.91393931 |
| 99 | MP0003303_peritoneal_inflammation | 0.90672117 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.89387823 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.89134932 |
| 102 | MP0008007_abnormal_cellular_replicative | 0.88624606 |
| 103 | MP0004019_abnormal_vitamin_homeostasis | 0.86480949 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.86463188 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.86463188 |
| 106 | MP0002396_abnormal_hematopoietic_system | 0.86034406 |
| 107 | MP0004510_myositis | 0.83302893 |
| 108 | MP0001663_abnormal_digestive_system | 0.82891911 |
| 109 | MP0000358_abnormal_cell_content/ | 0.82642818 |
| 110 | MP0001905_abnormal_dopamine_level | 0.82634115 |
| 111 | MP0003646_muscle_fatigue | 0.82453570 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.82194750 |
| 113 | MP0000490_abnormal_crypts_of | 0.81620425 |
| 114 | MP0008877_abnormal_DNA_methylation | 0.81229853 |
| 115 | MP0001919_abnormal_reproductive_system | 0.80297716 |
| 116 | MP0008873_increased_physiological_sensi | 0.80147647 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.76688902 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.76383350 |
| 119 | MP0003866_abnormal_defecation | 0.75206192 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.75130196 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.72254059 |
| 122 | MP0001661_extended_life_span | 0.70024663 |
| 123 | MP0000858_altered_metastatic_potential | 0.69871872 |
| 124 | MP0005647_abnormal_sex_gland | 0.69338600 |
| 125 | MP0005075_abnormal_melanosome_morpholog | 0.68096473 |
| 126 | MP0003698_abnormal_male_reproductive | 0.68085988 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.65192523 |
| 128 | MP0008058_abnormal_DNA_repair | 0.63062169 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.62895050 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.60571159 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.60103586 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.59825181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bronchitis (HP:0002837) | 4.53673901 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 4.34543450 |
| 3 | Recurrent sinusitis (HP:0011108) | 4.24965672 |
| 4 | Nasal polyposis (HP:0100582) | 4.23379161 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.05015658 |
| 6 | 3-Methylglutaconic aciduria (HP:0003535) | 3.94569746 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.92757388 |
| 8 | Petechiae (HP:0000967) | 3.87614331 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.85140677 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.82567028 |
| 11 | Hepatic necrosis (HP:0002605) | 3.80023468 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.74620883 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 3.68708836 |
| 14 | Increased CSF lactate (HP:0002490) | 3.58422278 |
| 15 | Bronchitis (HP:0012387) | 3.55053684 |
| 16 | Stomatitis (HP:0010280) | 3.55000355 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.44885053 |
| 18 | Acute encephalopathy (HP:0006846) | 3.41384932 |
| 19 | IgM deficiency (HP:0002850) | 3.41354541 |
| 20 | Progressive macrocephaly (HP:0004481) | 3.34757616 |
| 21 | Chronic otitis media (HP:0000389) | 3.34644146 |
| 22 | Renal Fanconi syndrome (HP:0001994) | 3.32020228 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 3.23935995 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.20007800 |
| 25 | Colitis (HP:0002583) | 3.17116879 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.16172811 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 3.09233267 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.02683879 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 3.01278291 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.01204374 |
| 31 | Prolonged bleeding time (HP:0003010) | 2.99841633 |
| 32 | Generalized aminoaciduria (HP:0002909) | 2.94384272 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 2.94084291 |
| 34 | Increased intramyocellular lipid droplets (HP:0012240) | 2.94000224 |
| 35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.90524783 |
| 36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.90524783 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.85174365 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84078298 |
| 39 | Xanthomatosis (HP:0000991) | 2.83429884 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.81403267 |
| 41 | Lymphopenia (HP:0001888) | 2.81276908 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.80428842 |
| 43 | Recurrent viral infections (HP:0004429) | 2.77386905 |
| 44 | IgA deficiency (HP:0002720) | 2.75395911 |
| 45 | Vasculitis (HP:0002633) | 2.75118306 |
| 46 | Recurrent otitis media (HP:0000403) | 2.74366403 |
| 47 | Increased muscle lipid content (HP:0009058) | 2.74116836 |
| 48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.73983700 |
| 49 | Deep venous thrombosis (HP:0002625) | 2.73980964 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.72866892 |
| 51 | Purpura (HP:0000979) | 2.72012756 |
| 52 | Hyperammonemia (HP:0001987) | 2.71083572 |
| 53 | Lactic acidosis (HP:0003128) | 2.69779713 |
| 54 | Type I transferrin isoform profile (HP:0003642) | 2.64851751 |
| 55 | Aplastic anemia (HP:0001915) | 2.63973078 |
| 56 | Emphysema (HP:0002097) | 2.60729161 |
| 57 | Increased serum lactate (HP:0002151) | 2.60172390 |
| 58 | Exertional dyspnea (HP:0002875) | 2.59209506 |
| 59 | Recurrent skin infections (HP:0001581) | 2.59171522 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.59040673 |
| 61 | Complement deficiency (HP:0004431) | 2.58870630 |
| 62 | Obstructive lung disease (HP:0006536) | 2.56138708 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56138708 |
| 64 | Cerebral edema (HP:0002181) | 2.55551448 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55088836 |
| 66 | Cellulitis (HP:0100658) | 2.53577086 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.52872390 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.51724567 |
| 69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50561229 |
| 70 | Chronic sinusitis (HP:0011109) | 2.47867012 |
| 71 | Respiratory failure (HP:0002878) | 2.47521679 |
| 72 | Exercise intolerance (HP:0003546) | 2.47456630 |
| 73 | Pustule (HP:0200039) | 2.47199851 |
| 74 | Abnormality of T cells (HP:0002843) | 2.45439585 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 2.44391172 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44280549 |
| 77 | Abnormality of T cell number (HP:0011839) | 2.39232256 |
| 78 | Prolonged partial thromboplastin time (HP:0003645) | 2.37358399 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.35081016 |
| 80 | Hyperglycinuria (HP:0003108) | 2.34848701 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.33622419 |
| 82 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33598733 |
| 83 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33598733 |
| 84 | Abnormal protein glycosylation (HP:0012346) | 2.33598733 |
| 85 | Abnormal glycosylation (HP:0012345) | 2.33598733 |
| 86 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.32462590 |
| 87 | IgG deficiency (HP:0004315) | 2.30732680 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.30700052 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.30545355 |
| 90 | Methylmalonic aciduria (HP:0012120) | 2.30292059 |
| 91 | Paralysis (HP:0003470) | 2.29479824 |
| 92 | Testicular atrophy (HP:0000029) | 2.28898966 |
| 93 | Meningitis (HP:0001287) | 2.27072512 |
| 94 | Myocardial infarction (HP:0001658) | 2.27040434 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25694901 |
| 96 | Abnormality of glycine metabolism (HP:0010895) | 2.25694901 |
| 97 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.24524988 |
| 98 | Respiratory difficulties (HP:0002880) | 2.22655787 |
| 99 | Neutropenia (HP:0001875) | 2.21495366 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20792634 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20109111 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.20109111 |
| 103 | Thrombocytosis (HP:0001894) | 2.20104579 |
| 104 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.19403582 |
| 105 | Bronchiectasis (HP:0002110) | 2.18463001 |
| 106 | Epistaxis (HP:0000421) | 2.17975492 |
| 107 | Abnormality of urine glucose concentration (HP:0011016) | 2.17389081 |
| 108 | Glycosuria (HP:0003076) | 2.17389081 |
| 109 | T lymphocytopenia (HP:0005403) | 2.14863139 |
| 110 | Joint hemorrhage (HP:0005261) | 2.13221489 |
| 111 | Lethargy (HP:0001254) | 2.13066241 |
| 112 | Recurrent pneumonia (HP:0006532) | 2.12620453 |
| 113 | Gingival bleeding (HP:0000225) | 2.12079979 |
| 114 | Methylmalonic acidemia (HP:0002912) | 2.10100297 |
| 115 | Abnormality of renal resorption (HP:0011038) | 2.09877882 |
| 116 | Increased serum ferritin (HP:0003281) | 2.09619198 |
| 117 | Severe visual impairment (HP:0001141) | 2.09132683 |
| 118 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.08997598 |
| 119 | Absent/shortened dynein arms (HP:0200106) | 2.08997598 |
| 120 | Hypolipoproteinemia (HP:0010981) | 2.08778001 |
| 121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.07943567 |
| 122 | Pancytopenia (HP:0001876) | 2.07511334 |
| 123 | Chronic bronchitis (HP:0004469) | 2.07123357 |
| 124 | Combined immunodeficiency (HP:0005387) | 2.06374268 |
| 125 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06346414 |
| 126 | Abnormality of methionine metabolism (HP:0010901) | 2.06282149 |
| 127 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05838036 |
| 128 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05838036 |
| 129 | Abnormal number of erythroid precursors (HP:0012131) | 2.04504913 |
| 130 | Hepatosplenomegaly (HP:0001433) | 2.03208891 |
| 131 | Fat malabsorption (HP:0002630) | 2.02706756 |
| 132 | Myositis (HP:0100614) | 2.02694350 |
| 133 | Abnormality of the prostate (HP:0008775) | 2.02682876 |
| 134 | Progressive microcephaly (HP:0000253) | 2.02128264 |
| 135 | Multiple enchondromatosis (HP:0005701) | 2.02124216 |
| 136 | Ketosis (HP:0001946) | 2.01836208 |
| 137 | Abnormality of complement system (HP:0005339) | 2.01378312 |
| 138 | Increased IgM level (HP:0003496) | 2.00985574 |
| 139 | Hypoproteinemia (HP:0003075) | 2.00332097 |
| 140 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98556289 |
| 141 | Albinism (HP:0001022) | 1.95058965 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.94674590 |
| 143 | Acute hepatic failure (HP:0006554) | 1.94653220 |
| 144 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.94327185 |
| 145 | Steatorrhea (HP:0002570) | 1.93264973 |
| 146 | Elevated hepatic transaminases (HP:0002910) | 1.92989044 |
| 147 | Urticaria (HP:0001025) | 1.92159577 |
| 148 | Leukopenia (HP:0001882) | 1.91508686 |
| 149 | Abnormality of lateral ventricle (HP:0030047) | 1.91248652 |
| 150 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91059024 |
| 151 | Verrucae (HP:0200043) | 1.90497001 |
| 152 | Papilloma (HP:0012740) | 1.90497001 |
| 153 | Chronic diarrhea (HP:0002028) | 1.90483739 |
| 154 | Mediastinal lymphadenopathy (HP:0100721) | 1.90251514 |
| 155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89884250 |
| 156 | Reduced antithrombin III activity (HP:0001976) | 1.89663623 |
| 157 | Skin rash (HP:0000988) | 1.89407502 |
| 158 | Renal cortical cysts (HP:0000803) | 1.89050587 |
| 159 | Vacuolated lymphocytes (HP:0001922) | 1.88420614 |
| 160 | Encephalitis (HP:0002383) | 1.87090941 |
| 161 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86696692 |
| 162 | Loss of speech (HP:0002371) | 1.86432845 |
| 163 | Abnormal pupillary function (HP:0007686) | 1.85318520 |
| 164 | Abnormality of macrophages (HP:0004311) | 1.85242043 |
| 165 | Abnormality of B cell number (HP:0010975) | 1.84800716 |
| 166 | B lymphocytopenia (HP:0010976) | 1.84800716 |
| 167 | Nausea (HP:0002018) | 1.84576071 |
| 168 | Hypertriglyceridemia (HP:0002155) | 1.84174171 |
| 169 | Optic disc pallor (HP:0000543) | 1.81795831 |
| 170 | Congenital stationary night blindness (HP:0007642) | 1.81395667 |
| 171 | CNS demyelination (HP:0007305) | 1.80876798 |
| 172 | Pulmonary infiltrates (HP:0002113) | 1.80461857 |
| 173 | Retrobulbar optic neuritis (HP:0100654) | 1.78105316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.29902584 |
| 2 | VRK2 | 3.92117764 |
| 3 | MAP3K14 | 2.71278293 |
| 4 | ERN1 | 2.51725645 |
| 5 | TYK2 | 2.49917461 |
| 6 | PDK3 | 2.48637678 |
| 7 | PDK4 | 2.48637678 |
| 8 | NUAK1 | 2.30741130 |
| 9 | STK10 | 2.28972083 |
| 10 | BLK | 2.24500556 |
| 11 | BMPR2 | 2.12897897 |
| 12 | RIPK4 | 2.12456607 |
| 13 | TBK1 | 2.11374199 |
| 14 | MST4 | 2.06834288 |
| 15 | BCKDK | 2.06626642 |
| 16 | TLK1 | 2.06392852 |
| 17 | EPHB1 | 2.02126405 |
| 18 | CSF1R | 1.95904917 |
| 19 | MAP4K2 | 1.91867091 |
| 20 | STK16 | 1.87874541 |
| 21 | ZAK | 1.87060861 |
| 22 | FGFR4 | 1.85102553 |
| 23 | TESK1 | 1.84410121 |
| 24 | TESK2 | 1.82486147 |
| 25 | BTK | 1.76923942 |
| 26 | MAP2K6 | 1.74134245 |
| 27 | IKBKB | 1.73399669 |
| 28 | ZAP70 | 1.67891021 |
| 29 | IKBKE | 1.67800186 |
| 30 | PDK2 | 1.62389947 |
| 31 | JAK3 | 1.60953319 |
| 32 | MAP3K13 | 1.57952801 |
| 33 | TNK2 | 1.52596188 |
| 34 | LRRK2 | 1.52148141 |
| 35 | GRK6 | 1.46377178 |
| 36 | CSK | 1.46275740 |
| 37 | KIT | 1.41947377 |
| 38 | NME1 | 1.39428970 |
| 39 | SYK | 1.39041682 |
| 40 | ITK | 1.30710234 |
| 41 | FES | 1.29668434 |
| 42 | SCYL2 | 1.29151979 |
| 43 | JAK1 | 1.25480379 |
| 44 | NEK2 | 1.24813312 |
| 45 | IRAK3 | 1.24644287 |
| 46 | NME2 | 1.19503630 |
| 47 | TXK | 1.15455621 |
| 48 | BUB1 | 1.15357482 |
| 49 | SRPK1 | 1.14434500 |
| 50 | KDR | 1.14197811 |
| 51 | ICK | 1.11084585 |
| 52 | CLK1 | 1.08588534 |
| 53 | ARAF | 1.08189885 |
| 54 | SIK1 | 1.06968423 |
| 55 | CHUK | 1.05392192 |
| 56 | STK39 | 1.05361228 |
| 57 | IRAK4 | 1.03427569 |
| 58 | LCK | 1.03176474 |
| 59 | CDK19 | 1.01532458 |
| 60 | DAPK1 | 1.00944021 |
| 61 | MAP3K10 | 1.00448694 |
| 62 | PIM1 | 1.00422229 |
| 63 | LYN | 0.97850807 |
| 64 | MUSK | 0.96750963 |
| 65 | CCNB1 | 0.96564109 |
| 66 | BMPR1B | 0.93682225 |
| 67 | GRK1 | 0.91731972 |
| 68 | EIF2AK1 | 0.91500336 |
| 69 | STK4 | 0.90231352 |
| 70 | TEC | 0.88711857 |
| 71 | ADRBK2 | 0.87940028 |
| 72 | PRKCQ | 0.86881079 |
| 73 | PBK | 0.86107466 |
| 74 | FRK | 0.83910962 |
| 75 | TGFBR2 | 0.82440260 |
| 76 | MAPK15 | 0.81173187 |
| 77 | RPS6KA4 | 0.80233092 |
| 78 | CDK12 | 0.77212717 |
| 79 | DYRK1B | 0.76779250 |
| 80 | TAOK2 | 0.76628212 |
| 81 | MAPKAPK3 | 0.75609438 |
| 82 | NLK | 0.75058339 |
| 83 | CDK4 | 0.72915095 |
| 84 | MAP3K8 | 0.71490292 |
| 85 | MAP3K11 | 0.70539330 |
| 86 | CSNK1G3 | 0.70266941 |
| 87 | DYRK3 | 0.69918639 |
| 88 | EIF2AK3 | 0.66479851 |
| 89 | TRIM28 | 0.66396206 |
| 90 | MAP2K3 | 0.65904921 |
| 91 | MAP3K12 | 0.65391397 |
| 92 | HCK | 0.64922577 |
| 93 | JAK2 | 0.64320192 |
| 94 | MARK3 | 0.64138403 |
| 95 | MAPK11 | 0.62078621 |
| 96 | PIM2 | 0.61420011 |
| 97 | CDK7 | 0.59190656 |
| 98 | ILK | 0.58315715 |
| 99 | DAPK3 | 0.57995416 |
| 100 | LIMK1 | 0.57764150 |
| 101 | CDK8 | 0.56975079 |
| 102 | WEE1 | 0.56787320 |
| 103 | ACVR1B | 0.56066752 |
| 104 | RPS6KA5 | 0.51107255 |
| 105 | IRAK1 | 0.50788978 |
| 106 | TRIB3 | 0.49741246 |
| 107 | PTK2B | 0.49134246 |
| 108 | AURKA | 0.49058685 |
| 109 | TAOK3 | 0.49023101 |
| 110 | ABL2 | 0.48967378 |
| 111 | PHKG2 | 0.48663316 |
| 112 | PHKG1 | 0.48663316 |
| 113 | FLT3 | 0.48580003 |
| 114 | NEK9 | 0.47321585 |
| 115 | GRK5 | 0.47114062 |
| 116 | MAP3K3 | 0.43771498 |
| 117 | MAP2K2 | 0.43333136 |
| 118 | PAK1 | 0.43190463 |
| 119 | MAPK7 | 0.41773893 |
| 120 | PASK | 0.41569836 |
| 121 | OXSR1 | 0.40473116 |
| 122 | CSNK1A1L | 0.39942225 |
| 123 | ABL1 | 0.38856263 |
| 124 | PTK6 | 0.38535824 |
| 125 | EIF2AK2 | 0.38256006 |
| 126 | PRKCH | 0.37601494 |
| 127 | PKN1 | 0.37531697 |
| 128 | WNK4 | 0.36632197 |
| 129 | PRKCD | 0.36421392 |
| 130 | PRKCI | 0.36347827 |
| 131 | MAPKAPK2 | 0.36006640 |
| 132 | CAMKK2 | 0.35829575 |
| 133 | SIK3 | 0.35311474 |
| 134 | CSNK1G1 | 0.34903015 |
| 135 | CSNK2A1 | 0.34425050 |
| 136 | PLK3 | 0.34027185 |
| 137 | MYLK | 0.34011134 |
| 138 | MATK | 0.33707151 |
| 139 | CSNK2A2 | 0.32597417 |
| 140 | ATR | 0.31982719 |
| 141 | PLK1 | 0.31951725 |
| 142 | CSNK1G2 | 0.31786079 |
| 143 | PDK1 | 0.31371281 |
| 144 | STK3 | 0.30570075 |
| 145 | EPHA3 | 0.30434558 |
| 146 | RPS6KB2 | 0.29615668 |
| 147 | CDC7 | 0.29436855 |
| 148 | GSK3A | 0.29043414 |
| 149 | MELK | 0.28306087 |
| 150 | PLK4 | 0.28033517 |
| 151 | VRK1 | 0.27439204 |
| 152 | TIE1 | 0.27246100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.25004477 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74981170 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.66150917 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31526233 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27158984 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.25380194 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.01946774 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00193593 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87413396 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86766926 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79956120 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78852890 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75619235 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 1.69533348 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69498916 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64210692 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.63247619 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62540583 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61224784 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.57423205 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53224829 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52627739 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52515618 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51707087 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.49228473 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.48919247 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47771666 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47634584 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.47467217 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46265596 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43458761 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41182788 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41061958 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38983478 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.36967748 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35485083 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35077842 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34393277 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.32210647 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31523777 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28401541 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25568959 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24476315 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24460948 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.24253662 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20181711 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19910360 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19094971 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18018305 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.16297087 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15811813 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14647414 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12450926 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11398233 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11179847 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08172392 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08030799 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06398381 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05881702 |
| 60 | Proteasome_Homo sapiens_hsa03050 | 1.05376280 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03959875 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02814091 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02673402 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 1.01542610 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00731289 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00374842 |
| 67 | Measles_Homo sapiens_hsa05162 | 1.00149045 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98705095 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96610380 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96052495 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94920011 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94591533 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.94015522 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93429047 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92811823 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87484722 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86785739 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86731597 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86333077 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86331561 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85861815 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85748361 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.84908576 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.84734520 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81447256 |
| 86 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81227337 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79895730 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77045188 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75703020 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74367749 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74365710 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.72403770 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71495844 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.71182719 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69822662 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69696224 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68557125 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68554018 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66572475 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64319860 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63938935 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.61552468 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61473432 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61006074 |
| 105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60971872 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60826872 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.59207002 |
| 108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58951947 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58129626 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57459992 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55997023 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55358188 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53242789 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52931353 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52319632 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52272984 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.51815288 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51708521 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51682154 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50900238 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.49954195 |
| 122 | RNA transport_Homo sapiens_hsa03013 | 0.49934054 |
| 123 | Malaria_Homo sapiens_hsa05144 | 0.49151735 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48733545 |
| 125 | Spliceosome_Homo sapiens_hsa03040 | 0.48233375 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.47546843 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47273569 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47190036 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46529715 |
| 130 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46318490 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45496548 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43448487 |
| 133 | Asthma_Homo sapiens_hsa05310 | 0.42975403 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42585842 |
| 135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41451806 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.40876809 |
| 137 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40011945 |
| 138 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36427353 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.34469526 |

